Lynx1 Capital Management LP

Korro Bio, Inc. · 10% Owner

Lynx1 Capital Management LP is listed in public filings as 10 percent owner. This Lynx1 Capital Management LP insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Korro Bio, Inc. (KRRO), TScan Therapeutics, Inc. (TCRX), Cullinan Therapeutics, Inc. (CGEM), and Passage Bio, Inc. (PASG). Investors use Lynx1 Capital Management LP's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

History Trades

CompanyValueActionPriceCurrent Price
TScan Therapeutics, Inc.TCRX$5.6k6.2k sharesBuyDec 23, 2025$0.8989--
TScan Therapeutics, Inc.TCRX$68k75.5k sharesBuyDec 22, 2025$0.90--
TScan Therapeutics, Inc.TCRX$72k80.1k sharesBuyDec 19, 2025$0.8989--
Cullinan Therapeutics, Inc.CGEM$1.4M165.7k sharesBuyOct 28, 2025$8.40--
Cullinan Therapeutics, Inc.CGEM$253k32.2k sharesBuyOct 17, 2025$7.84--
Cullinan Therapeutics, Inc.CGEM$1.3M150k sharesBuyOct 16, 2025$8.86--
Cullinan Therapeutics, Inc.CGEM$409k51.5k sharesBuyOct 15, 2025$7.94--
Cullinan Therapeutics, Inc.CGEM$114k15k sharesBuyOct 14, 2025$7.59--
Cullinan Therapeutics, Inc.CGEM$2.0M277.3k sharesBuyOct 10, 2025$7.36--
Cullinan Therapeutics, Inc.CGEM$4.2M626k sharesBuyOct 9, 2025$6.70--
Cullinan Therapeutics, Inc.CGEM$3.6M556.3k sharesBuyOct 8, 2025$6.46--
Passage Bio, Inc.PASG$83k11.9k sharesBuySep 15, 2025$6.99--
Passage Bio, Inc.PASG$138k19.8k sharesBuySep 12, 2025$6.99--
Passage Bio, Inc.PASG$2.3k325 sharesBuySep 11, 2025$6.96--
Passage Bio, Inc.PASG$379k66.4k sharesBuyJul 24, 2025$5.71--
Passage Bio, Inc.PASG$283k49.3k sharesBuyJul 23, 2025$5.74--
Passage Bio, Inc.PASG$71k13.1k sharesBuyJul 22, 2025$5.44--
TScan Therapeutics, Inc.TCRX$1.4M1.2M sharesBuyMay 20, 2025$1.20--
TScan Therapeutics, Inc.TCRX$1.7M1.4M sharesBuyMay 19, 2025$1.20--
Passage Bio, Inc.PASG$241k373.6k sharesBuyDec 27, 2024$0.6451--
TScan Therapeutics, Inc.TCRX$7507.5M sharesBuyDec 26, 2024$0.0001--
TScan Therapeutics, Inc.TCRX$290k100k sharesBuyDec 13, 2024$2.90--
TScan Therapeutics, Inc.TCRX$96k31.8k sharesBuyDec 12, 2024$3.01--
Passage Bio, Inc.PASG$20k29.3k sharesBuyNov 27, 2024$0.6711--
Passage Bio, Inc.PASG$118k167.1k sharesBuyNov 26, 2024$0.7075--
Passage Bio, Inc.PASG$147k260k sharesBuyNov 25, 2024$0.5641--
TScan Therapeutics, Inc.TCRX$4.1k947 sharesBuyNov 15, 2024$4.34--